Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Clinical Application of $^{18}F-FDG$ PET in Head and Neck Cancer

두경부 종양에서 $^{18}F-FDG$ PET의 임상이용

  • Kim, Jae-Seung (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Bae, Jin-Ho (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • 김재승 (울산의대 서울아산병원 핵의학과) ;
  • 배진호 (울산의대 서울아산병원 핵의학과)
  • Published : 2008.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Head and neck cancer is the sixth most common type of human cancer worldwide. Squamous cell carcinoma is the most common cancer of the head and neck. Since $^{18}F-FDG$ PET is very sensitive to detecting squamous cell carcinoma, it has been widely used in patients with head and neck cancers for initial staging, management of recurrent cancers, and therapeutic monitoring. According to clinical research data, $^{18}F-FDG$ PET is expected to be a very helpful diagnostic tool in the management of head and neck cancer.

Keywords